Kindred Healthcare (NYSE:KND) came back today with a big new offer for Gentiva (NASDAQ:GTIV) shareholders as it struggles to acquire the home health care and hospice provider. At $16 a share, it's an enormous premium to what Gentiva traded at previous to the first offer being made public (although, to be fair, it's a slight discount to what Gentiva trades at today).

But let's ignore the price for the moment. Here are three key benefits a merger with Kindred would offer to Gentiva shareholders.